Star OUTiCO Launches New Brand Identity

Star OUTiCO, a market-leading provider of digitally enabled commercial services to the pharmaceutical industry and is part of the global Uniphar Group, has unveiled a new brand identity. The company collaborates with Uniphar Group, one of the largest and most innovative pharmaceutical and healthcare companies in the world, to help its clients achieve an impact on their businesses in a rapidly changing world. It is essential to stay up to date with the latest developments in a rapidly changing world, including the COVID-19 regulatory.


Star OUTiCO Outsourcing Pharma has been the leader in the field of digitally-enabled commercial services for the pharmaceutical industry. The company is part of the Uniphar Group and recently launched a new brand identity. The new brand’s identity reinforces the firm’s commitment to improve customer engagement at any point in the commercial lifecycle. The new brand is a result of a significant investment in digital capabilities, such as the AXiOM platform, which gathers real-time program data from a variety of sources.

The Star OUTiCO Outsourcing Pharma has offices across the UK, Ireland and Europe to offer a range of commercial services to health care companies. This comprehensive approach to pharmaceuticals that is omnichannel can help companies increase accessibility, boost sales, and increase brand awareness.

Star Medical

Star Medical Outsourcing Pharma, an outsourcing firm that offers full-service services is a partner with a range of pharmaceutical companies in the UK. The company offers a range of career opportunities such as executive and graduate positions. It has strong international presence with teams in the UK, Ireland, and Europe.

Leading players in the pharmaceutical contract sales outsourcing (CSO) market in Europe

The outsourcing of pharmaceutical contract sales market in Europe is highly consolidated, with only a few leading players dominating the industry. The top players in the market are looking at mergers, acquisitions, and expanding their product ranges. Star outico Outsourcing Pharma and NiSiPharm GmbH are two of the major players in this market.

Pharmaceutical Recruitment Agency of the key segments of this market are cardiovascular disorders, oncology, metabolic disorders, infectious diseases, and neurology. Outsourcing is becoming more prevalent in the pharmaceutical sector, because of the cost-constrained environment and the necessity for flexibility in operation.

Digital capabilities

Star OUTiCO Pharma offers a diverse array of digital capabilities that help the marketing and sales of medical device and pharmaceutical companies. The company’s intelligent solutions and data-driven strategies allow companies to make better business decisions. The multidisciplinary team of the company brings a unique combination of expertise and experience to deliver results.

First, businesses must determine valuable sources of unique value in the disease areas. Once they have identified these, they will be able to define their flagship initiatives. These initiatives should be focused on addressing two to three specific use cases. One of these initiatives could be building a digital ecosystem to support patient adherence to the medication.

Global presence

Star OUTiCO is one of the leading providers of outsourced digitally enabled commercial services for the pharmaceutical industry. It is part of the Uniphar Group, which has global operations and has been working with the pharmaceutical industry since. Star OUTiCO focuses its efforts on helping pharmaceutical companies improve their commercial performance and rapidly adapt to the rapidly changing pharmaceutical landscape. The company has offices throughout the UK, Ireland, Europe and other countries.

The pharmaceutical contract sales outsourcing market is highly consolidated in Europe with a few leading players dominating the market. These companies make use of mergers and acquisitions aswell expanding their product portfolios to expand their presence in the region. Star OUTiCO, NiSiPharm GmbH are some of the most prominent players in the market.